Clinical trials recruiting for Tuberous Sclerosis Complex
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Sirolimus | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Ohio | 2 |
| Alabama | 1 |
| California | 1 |
| Colorado | 1 |
| Illinois | 1 |
| Massachusetts | 1 |
| Missouri | 1 |
| North Carolina | 1 |
| Texas | 1 |
| Washington | 1 |
Top cities
Self-screener
Recruiting trials
- A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines
- Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex
- Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
- Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
Related conditions
Trials recruiting for Tuberous Sclerosis Complex often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Tuberous Sclerosis Complex trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.